Cancer Cell
-
Publication Venue For
- Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. 35:267-282.e7. 2019
- Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.. 34:893-905.e8. 2018
- Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. 32:377-391.e9. 2017
- Glioma Stem-like Cells Keep Their H3.3 Variant Levels at Bay.. 28:679-680. 2015
- LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.. 23:143-158. 2013
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth. 19:792-804. 2011
- Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma (DOI:10.1016/j.ccr.2008.12.016). 16:267. 2009
- 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition.. 16:195-207. 2009
- Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases.. 16:33-43. 2009
- An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.. 13:11-22. 2008
- Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.. 12:528-541. 2007
- New breast cancer genes-discovery at the intersection of complex data sets.. 12:497-499. 2007
- Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.. 12:215-229. 2007
- Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.. 12:115-130. 2007
- RXR is an essential component of the oncogenic PML/RARA complex in vivo.. 12:23-35. 2007
- Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.. 12:52-65. 2007
- Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia.. 10:401-411. 2006
- mILC-ing the mouse mammary gland: A model for invasive lobular carcinoma.. 10:347-349. 2006
- Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.. 8:381-392. 2005
- Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.. 8:99-110. 2005
- Activation of RalA is critical for Ras-induced tumorigenesis of human cells.. 7:533-545. 2005
- Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway.. 7:575-589. 2005
- Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development.. 7:313-324. 2005
- Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.. 6:507-516. 2004
- The convergence of cancer prevention and therapy in early-phase clinical drug development.. 6:321-326. 2004
- Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.. 6:251-261. 2004
- Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.. 5:429-441. 2004
- Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.. 5:329-339. 2004
- Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers.. 4:245-247. 2003
- Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene.. 3:297-302. 2003
- Optimal gene expression analysis by microarrays.. 2:353-361. 2002
- Gene expression correlates of clinical prostate cancer behavior.. 1:203-209. 2002
- ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.. 1:145-155. 2002